Anti-IGF1R / CD221 Reference Antibody (robatumumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (robatumumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (Immunomedics patent anti-IGF-1R)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (ganitumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (figitumumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Anti-IGF1R / CD221 Reference Antibody (dalotuzumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (lonigutamAb)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human |
Anti-IGF1R / CD221 Reference Antibody (cixutumumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Mouse |
Anti-IGF1R / CD221 Reference Antibody (teprotumumab)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |
Anti-IGF1R / CD221 Reference Antibody (Lonigutamab-MMAE)
Applications | Animal Model, ELISA, FACS, FN, Kinetics |
Reactivities | Human, Cynomolgus |